167 related articles for article (PubMed ID: 23686311)
21. Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation.
Ishikawa H; Tsuyama N; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X; Kawano MM
Leuk Lymphoma; 2003 Sep; 44(9):1477-81. PubMed ID: 14565647
[TBL] [Abstract][Full Text] [Related]
22. Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase.
Takahashi-Tezuka M; Yoshida Y; Fukada T; Ohtani T; Yamanaka Y; Nishida K; Nakajima K; Hibi M; Hirano T
Mol Cell Biol; 1998 Jul; 18(7):4109-17. PubMed ID: 9632795
[TBL] [Abstract][Full Text] [Related]
23. Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.
Wilmes S; Jeffrey PA; Martinez-Fabregas J; Hafer M; Fyfe PK; Pohler E; Gaggero S; López-García M; Lythe G; Taylor C; Guerrier T; Launay D; Mitra S; Piehler J; Molina-París C; Moraga I
Elife; 2021 Apr; 10():. PubMed ID: 33871355
[TBL] [Abstract][Full Text] [Related]
24. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.
Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K
Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666
[TBL] [Abstract][Full Text] [Related]
25. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
[TBL] [Abstract][Full Text] [Related]
26. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase.
Boulton TG; Zhong Z; Wen Z; Darnell JE; Stahl N; Yancopoulos GD
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6915-9. PubMed ID: 7624343
[TBL] [Abstract][Full Text] [Related]
27. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
28. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of the human gp130 promoter. Regulation by STATS.
O'Brien CA; Manolagas SC
J Biol Chem; 1997 Jun; 272(23):15003-10. PubMed ID: 9169475
[TBL] [Abstract][Full Text] [Related]
31. Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress.
Chen Q; Wang WC; Bruce R; Li H; Schleider DM; Mulbury MJ; Bain MD; Wallace PK; Baumann H; Evans SS
Immunity; 2004 Jan; 20(1):59-70. PubMed ID: 14738765
[TBL] [Abstract][Full Text] [Related]
32. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
34. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
[TBL] [Abstract][Full Text] [Related]
35. Signaling pathway of ciliary neurotrophic factor in neuroblastoma cell lines.
Kuroda H; Sugimoto T; Horii Y; Sawada T
Med Pediatr Oncol; 2001 Jan; 36(1):118-21. PubMed ID: 11464862
[TBL] [Abstract][Full Text] [Related]
36. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
[TBL] [Abstract][Full Text] [Related]
37. The multi-site docking protein Grb2-associated binder 1 (Gab1) enhances interleukin-6-induced MAPK-pathway activation in an SHP2-, Grb2-, and time-dependent manner.
Bongartz H; Gille K; Hessenkemper W; Mandel K; Lewitzky M; Feller SM; Schaper F
Cell Commun Signal; 2019 Oct; 17(1):135. PubMed ID: 31651330
[TBL] [Abstract][Full Text] [Related]
38. Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis.
Miller A; Brooks GD; McLeod L; Ruwanpura S; Jenkins BJ
Oncogene; 2015 Mar; 34(12):1510-9. PubMed ID: 24727895
[TBL] [Abstract][Full Text] [Related]
39. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression.
Legendre F; Dudhia J; Pujol JP; Bogdanowicz P
J Biol Chem; 2003 Jan; 278(5):2903-12. PubMed ID: 12419823
[TBL] [Abstract][Full Text] [Related]
40. The inhibition of N-glycosylation of glycoprotein 130 molecule abolishes STAT3 activation by IL-6 family cytokines in cultured cardiac myocytes.
Matsuo R; Morihara H; Mohri T; Murasawa S; Takewaki K; Nakayama H; Maeda M; Fujio Y
PLoS One; 2014; 9(10):e111097. PubMed ID: 25340554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
